FDA Panel Backs Astellas Bladder Drug Despite Concerns
In a split vote Thursday, a U.S. Food and Drug Administration advisory panel recommended approving an Astellas Pharma US Inc. bladder-control drug despite several panelists' reservations about the drug's effectiveness and...To view the full article, register now.
Already a subscriber? Click here to view full article